Progyny, Inc.

NASDAQ:PGNY

Medical - Healthcare Information Services

Healthcare
$36.16 -0.19%

-$0.05 today

Market cap
$2.66B
Beta
1.04
P/E (TTM)
31.4
EPS (TTM)
$0.84
52W Low $16.10High $28.75

Volume 0.88M

Average 1.49M

PGNY Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

Progyny, Inc.NASDAQ: PGNY

Net Change in Cash · Q2 FY2026 · quarter ended Jun 2026

Net change in cash growth accelerates

Q2 FY2026 net change in cash of $40.41M rose 73.4% year over year, ahead of the +7.9% change in trailing-twelve-month net change in cash. Sequentially, it rose 98.0% from the prior quarter.

Context

  • Net change in cash amounted to 3.7% of revenue in FY2025, down 1.8 pp from a year earlier.
  • Net change in cash increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +73.4% holds above the trailing-twelve-month pace of +7.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$40.41M+98.0% QoQ
Last fiscal yearDec 2025
-$48.12M-174.0% YoY
LTMJun 2026
$40.55M+7.9% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+73.4%——
1 year-174.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
(48.12M) USD
Year-over-year change
-174.0%

Net Change in Cash vs competitors

How PGNY compares with its peers on the latest reported figures

  • PGNY's LTM Jun 2026 net change in cash of $40.55M is the smallest of the 3 companies compared; the peer median is $51.96M.
  • Its year-over-year change of +7.9% is the lowest of 3, against a peer median of +323.4%.
  • Net change in cash amounts to 3.1% of revenue for PGNY, versus a peer median of 28.7%.
PGNY Competitors Peer median
Net Change in Cash for PGNY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OMDAOmada HealthLTM Mar 2026$152.37M +530.7%—53.8%
HQYHealthEquity, Inc.LTM Jul 2026$48.46M +116.0%-7.3%3.6%
PGNYProgyny, Inc.LTM Jun 2026$40.55M +7.9%—3.1%
Peer median (excluding PGNY) $51.96M+323.4%-7.3%28.7%

Competitors are the stored peer set for PGNY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income65.77M30.36M62.04M54.34M58.52M
Depreciation & Amortization1.3M1.6M2.28M3.18M4.95M
Deferred Income Tax(33.3M)(6.62M)3.75M(10.46M)(8.12M)
Stock-Based Compensation33.71M100.75M122.61M128.13M131.87M
Change in Working Capital(51.26M)(59.49M)(17.42M)(11.78M)2.8M
Accounts Receivables(68.68M)(119.3M)(21.74M)(9.87M)(5.12M)
Inventory00000
Accounts Payables17.84M47.69M16.24M(30.27M)28.75M
Other Working Capital(421K)12.12M(11.92M)28.37M(20.84M)
Other Non-Cash Items9.82M13.79M15.56M15.7M20.17M
Operating Cash Flow26.04M80.4M188.81M179.11M210.19M
Capital Expenditures(2.13M)(3.24M)(3.64M)(5.41M)(18.41M)
Acquisitions (Net)000(5.3M)(9.34M)
Purchases of Investments(111.48M)(163.33M)(429.69M)(170.34M)(354.96M)
Sales of Investments122.37M122.71M232.81M376.84M223.7M
Other Investing Activities00000
Investing Cash Flow8.77M(43.87M)(200.53M)195.79M(159.01M)
Debt Repayment00000
Common Stock Issued4.27M4.23M6.13M2.4M1.23M
Common Stock Repurchased000(300.28M)(81.66M)
Dividends Paid00000
Other Financing Activities(17.97M)(12.09M)(17.2M)(12M)(18.94M)
Financing Cash Flow(13.7M)(7.86M)(11.07M)(309.88M)(99.36M)
Effect of Forex Changes001K1K62K
Net Change in Cash21.11M28.67M(22.78M)65.02M(48.12M)
Free Cash Flow23.91M77.15M185.17M173.7M191.78M

Progyny, Inc.

NASDAQ:PGNY

Intrinsic Alpha fair value

Locked

Current Price

$36.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.